Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The FGF metabolic axis
Xiaokun Li
Frontiers of Medicine (2019) Vol. 13, Iss. 5, pp. 511-530
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

FGF Signaling Pathway: A Key Regulator of Stem Cell Pluripotency
Majid Mossahebi‐Mohammadi, Meiyu Quan, Jin‐San Zhang, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 233
Growth factors-based therapeutic strategies and their underlying signaling mechanisms for peripheral nerve regeneration
Rui Li, Duo-hui Li, Hongyu Zhang, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 10, pp. 1289-1300
Open Access | Times Cited: 175
Pathobiology of the Klotho Antiaging Protein and Therapeutic Considerations
Gérald J. Prud’homme, Mervé Kurt, Qinghua Wang
Frontiers in Aging (2022) Vol. 3
Open Access | Times Cited: 122
An in situ tissue engineering scaffold with growth factors combining angiogenesis and osteoimmunomodulatory functions for advanced periodontal bone regeneration
Tian Ding, Wenyan Kang, Jianhua Li, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 107
New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 96
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
Masuko Katoh, Yohann Loriot, Giovanni Brandi, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 312-329
Closed Access | Times Cited: 60
FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond
Stephen A. Harrison, Timothy P. Rolph, Madeline Knott, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 562-576
Closed Access | Times Cited: 32
FGF-based drug discovery: advances and challenges
Gaozhi Chen, Lingfeng Chen, Xiaokun Li, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 4
Corneal first aid lens: Collagen-based hydrogels loading aFGF as contact lens for treating corneal injuries
Anqi Ye, Hao Mei, Xinyuan Zhang, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 251-265
Closed Access | Times Cited: 2
RETRACTED: Healing potential of Spirulina platensis for skin wounds by modulating bFGF, VEGF, TGF-ß1 and α-SMA genes expression targeting angiogenesis and scar tissue formation in the rat model
Zizy I. Elbialy, Doaa H. Assar, Aml Abdelnaby, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111349-111349
Open Access | Times Cited: 88
Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage
Rossana Franzin, Alessandra Stasi, Marco Fiorentino, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 72
Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine
Huiling Tan, Yue Tong, Zhengfang Chen, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 1, pp. 66-88
Open Access | Times Cited: 50
The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model
Redin A. Spann, Christopher D. Morrison, Laura J. den Hartigh
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 44
The potential function and clinical application of FGF21 in metabolic diseases
Zhiwei Chen, Lili Yang, Yang Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
Role of signaling pathways in age-related orthopedic diseases: focus on the fibroblast growth factor family
Heng-Zhen Li, Jing-lve Zhang, Dong-Liang Yuan, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Fibroblast growth factor signaling in macrophage polarization: impact on health and diseases
Luyao Shen, Yongsheng Li, Huakan Zhao
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Activating Adenosine Monophosphate–Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice
Qian Lin, Zhifeng Huang, Genxiang Cai, et al.
Hepatology (2020) Vol. 73, Iss. 6, pp. 2206-2222
Open Access | Times Cited: 65
FGF21 in obesity and cancer: New insights
Weiqin Lu, Xiaokun Li, Yongde Luo
Cancer Letters (2020) Vol. 499, pp. 5-13
Open Access | Times Cited: 63
FGF21 Attenuated LPS-Induced Depressive-Like Behavior via Inhibiting the Inflammatory Pathway
Xue Wang, Liyun Zhu, Jian Hu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 58
Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis
Joeri Lambrecht, Leo A. van Grunsven, Frank Tacke
Expert Opinion on Pharmacotherapy (2020) Vol. 21, Iss. 13, pp. 1637-1649
Closed Access | Times Cited: 54
Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease
Sarah Altajar, György Baffy
Journal of Clinical and Translational Hepatology (2020) Vol. 8, Iss. 4, pp. 1-10
Open Access | Times Cited: 54
Dual target inhibitors based on EGFR: Promising anticancer agents for the treatment of cancers (2017-)
Liping Hu, Mengmeng Fan, Shengmin Shi, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113963-113963
Closed Access | Times Cited: 50
Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer
Chiara Francavilla, Ciara O’Brien
Open Biology (2022) Vol. 12, Iss. 2
Open Access | Times Cited: 37
Programmed ageing: decline of stem cell renewal, immunosenescence, and Alzheimer's disease
Richard Lathe, David St Clair
Biological reviews/Biological reviews of the Cambridge Philosophical Society (2023) Vol. 98, Iss. 4, pp. 1424-1458
Open Access | Times Cited: 18
Regulation of bone homeostasis: signaling pathways and therapeutic targets
Zebin Wu, Wenming Li, Kunlong Jiang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top